These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9291738)

  • 21. Bleeding and hypercoagulable problems in women.
    Konkle BA
    Clin Adv Hematol Oncol; 2004 Aug; 2(8):515-6. PubMed ID: 16163231
    [No Abstract]   [Full Text] [Related]  

  • 22. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The significance of APC resistance (activated protein C) for clinical practice].
    Lämmle B; Demarmels Biasiutti F; Wuillemin WA; Stucki B; Furlan M
    Praxis (Bern 1994); 1997 Jan; 86(5):154-61. PubMed ID: 9064734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activated protein C resistance--a recently discovered hereditary thrombophilia].
    Moland L; Sandset PM
    Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3590-5. PubMed ID: 9820002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Thrombophilias associated with cerebral venous thrombosis].
    Schlück E; Rodier G; Derouiche F; Bronner P; Boulay C; Courtois S; Cohen E
    Rev Neurol (Paris); 2002 May; 158(5 Pt 1):543-52. PubMed ID: 12072822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of thrombophilia based on coagulation and genetic studies].
    Bałszan-Kowalska I
    Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factor V Leiden and thrombophilia].
    Mahassen P; Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(2):17-22. PubMed ID: 9534269
    [No Abstract]   [Full Text] [Related]  

  • 29. Resistance to activated protein C: role in venous and arterial thrombosis.
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Biomed Pharmacother; 1996; 50(6-7):254-60. PubMed ID: 8952864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
    Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E
    Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor V Leiden mutation in women with idiopathic pulmonary embolism.
    Andersen BS; Olsen J
    Thromb Haemost; 1997 Oct; 78(4):1298. PubMed ID: 9365004
    [No Abstract]   [Full Text] [Related]  

  • 32. Factor V Leiden thrombophilia: presentation of three patients and a literature review.
    Cruz-Amy M; Hunter-Mellado R
    Bol Asoc Med P R; 2006; 98(3):213-21. PubMed ID: 19610561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [National evaluation of the diagnosis of activated protein C resistance].
    Montiel-Manzano G; de la Peña-Díaz A; Majluf-Cruz A; Cesarman-Maus G; Corona-de la Peña N; Cruz-Cruz D; Gaminio E; Martínez-Murillo C; Mayagoitia T; Miranda-Peralta E; Poblete T; Quintana-Martínez S; Ramírez R; Razo D; Ruiz de Chávez-Ochoa A; Reyes-Núñez VA; Salazar R; Vicencio-Santiago GV; Villa R
    Rev Invest Clin; 2003; 55(3):358-69. PubMed ID: 14515684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple and reliable factor V genotyping by PNA-mediated PCR clamping.
    Behn M; Schuermann M
    Thromb Haemost; 1998 Apr; 79(4):773-7. PubMed ID: 9569191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma resistance to activated protein C: an important link between venous thromboembolism and combined oral contraceptives--a short review.
    Jespersen J
    Eur J Contracept Reprod Health Care; 1996; 1(1):3-11. PubMed ID: 9678132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analgesia for childbirth in a patient with factor V Leiden mutation].
    Puértolas Ortega M; Izquierdo Villarroya B; Oliva Perales P; Lafuente Ojeda N; Izquierdo Villarroya J; Ruiz Pérez R
    Rev Esp Anestesiol Reanim; 2007 Jan; 54(1):41-4. PubMed ID: 17319433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Resistance to activated protein C disclosed by postphlebitic disease. Two cases].
    Foueré S; Lestang P; Cosnes A; Gouault-Heilmann M; Revuz J
    Ann Dermatol Venereol; 1996; 123(1):24-5. PubMed ID: 8734112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genomic diagnosis of thrombophilia in women: clinical relevance].
    Luxembourg B; Lindhoff-Last E
    Hamostaseologie; 2007 Feb; 27(1):22-31. PubMed ID: 17279273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study of the Leiden mutation (factor VQ 506), the most frequent cause of thrombophilia, in 116 thrombosis patients].
    Nagy A; Melegh B; Losonczy H
    Orv Hetil; 1997 Nov; 138(44):2797-800. PubMed ID: 9411348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The factor V gene A4070G mutation and the risk of venous thrombosis.
    Alhenc-Gelas M; Nicaud V; Gandrille S; van Dreden P; Amiral J; Aubry ML; Fiessinger JN; Emmerich J; Aiach M
    Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.